The cognitive effects of conjugated equine estrogens depend on whether menopause etiology is transitional or surgical

Jazmin I. Acosta, Loretta P. Mayer, Brittany Braden, Sean Nonnenmacher, Sarah E. Mennenga, Heather Bimonte-Nelson

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

The question of whether to take hormone therapy (HT) will impact every woman as she enters reproductive senescence. In women, studies suggest that ovarian hormone loss associated with menopause has deleterious cognitive effects. Results from clinical studies evaluating whether estrogen-containing HT mitigates these effects, and benefits cognition, are discrepant. Type of menopause, surgical vs. transitional, impacts cognitive outcome in women. However, whether type of menopause impacts cognitive effects of HT has not been methodically tested in women or an animal model. We used the 4-vinylcyclohexene diepoxide rodent model of ovarian follicle depletion, which mimics transitional menopause, and the traditional rat model of menopause, ovariectomy, to cognitively test the most commonly prescribed estrogen therapy in the United States, conjugated equine estrogens (Premarin). Here we show conjugated equine estrogens benefited cognition in surgically menopausal rats, but, in contrast, impaired cognition in transitionally menopausal rats. Androstenedione, released from the residual transitional menopausal ovary, was positively associated with impaired performance, replicating our previous findings in 4-vinylcyclohexene diepoxide animals. The current findings are especially salient given that no clinical study testing cognition has methodically separated these two populations of menopausal women for analysis. That we now show surgical vs. transitional modes of menopause result in disparate cognitive effects of HT has implications for future research and treatments optimizing HT for menopausal women.

Original languageEnglish (US)
Pages (from-to)3795-3804
Number of pages10
JournalEndocrinology
Volume151
Issue number8
DOIs
StatePublished - Aug 2010

Fingerprint

Conjugated (USP) Estrogens
Menopause
Hormones
Cognition
Therapeutics
Estrogens
Ovarian Follicle
Androstenedione
Ovariectomy
Ovary
Rodentia
Animal Models

ASJC Scopus subject areas

  • Endocrinology

Cite this

The cognitive effects of conjugated equine estrogens depend on whether menopause etiology is transitional or surgical. / Acosta, Jazmin I.; Mayer, Loretta P.; Braden, Brittany; Nonnenmacher, Sean; Mennenga, Sarah E.; Bimonte-Nelson, Heather.

In: Endocrinology, Vol. 151, No. 8, 08.2010, p. 3795-3804.

Research output: Contribution to journalArticle

Acosta, Jazmin I. ; Mayer, Loretta P. ; Braden, Brittany ; Nonnenmacher, Sean ; Mennenga, Sarah E. ; Bimonte-Nelson, Heather. / The cognitive effects of conjugated equine estrogens depend on whether menopause etiology is transitional or surgical. In: Endocrinology. 2010 ; Vol. 151, No. 8. pp. 3795-3804.
@article{35a4d6ad25624a5c8aad3cfe3cfa6bc7,
title = "The cognitive effects of conjugated equine estrogens depend on whether menopause etiology is transitional or surgical",
abstract = "The question of whether to take hormone therapy (HT) will impact every woman as she enters reproductive senescence. In women, studies suggest that ovarian hormone loss associated with menopause has deleterious cognitive effects. Results from clinical studies evaluating whether estrogen-containing HT mitigates these effects, and benefits cognition, are discrepant. Type of menopause, surgical vs. transitional, impacts cognitive outcome in women. However, whether type of menopause impacts cognitive effects of HT has not been methodically tested in women or an animal model. We used the 4-vinylcyclohexene diepoxide rodent model of ovarian follicle depletion, which mimics transitional menopause, and the traditional rat model of menopause, ovariectomy, to cognitively test the most commonly prescribed estrogen therapy in the United States, conjugated equine estrogens (Premarin). Here we show conjugated equine estrogens benefited cognition in surgically menopausal rats, but, in contrast, impaired cognition in transitionally menopausal rats. Androstenedione, released from the residual transitional menopausal ovary, was positively associated with impaired performance, replicating our previous findings in 4-vinylcyclohexene diepoxide animals. The current findings are especially salient given that no clinical study testing cognition has methodically separated these two populations of menopausal women for analysis. That we now show surgical vs. transitional modes of menopause result in disparate cognitive effects of HT has implications for future research and treatments optimizing HT for menopausal women.",
author = "Acosta, {Jazmin I.} and Mayer, {Loretta P.} and Brittany Braden and Sean Nonnenmacher and Mennenga, {Sarah E.} and Heather Bimonte-Nelson",
year = "2010",
month = "8",
doi = "10.1210/en.2010-0055",
language = "English (US)",
volume = "151",
pages = "3795--3804",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "8",

}

TY - JOUR

T1 - The cognitive effects of conjugated equine estrogens depend on whether menopause etiology is transitional or surgical

AU - Acosta, Jazmin I.

AU - Mayer, Loretta P.

AU - Braden, Brittany

AU - Nonnenmacher, Sean

AU - Mennenga, Sarah E.

AU - Bimonte-Nelson, Heather

PY - 2010/8

Y1 - 2010/8

N2 - The question of whether to take hormone therapy (HT) will impact every woman as she enters reproductive senescence. In women, studies suggest that ovarian hormone loss associated with menopause has deleterious cognitive effects. Results from clinical studies evaluating whether estrogen-containing HT mitigates these effects, and benefits cognition, are discrepant. Type of menopause, surgical vs. transitional, impacts cognitive outcome in women. However, whether type of menopause impacts cognitive effects of HT has not been methodically tested in women or an animal model. We used the 4-vinylcyclohexene diepoxide rodent model of ovarian follicle depletion, which mimics transitional menopause, and the traditional rat model of menopause, ovariectomy, to cognitively test the most commonly prescribed estrogen therapy in the United States, conjugated equine estrogens (Premarin). Here we show conjugated equine estrogens benefited cognition in surgically menopausal rats, but, in contrast, impaired cognition in transitionally menopausal rats. Androstenedione, released from the residual transitional menopausal ovary, was positively associated with impaired performance, replicating our previous findings in 4-vinylcyclohexene diepoxide animals. The current findings are especially salient given that no clinical study testing cognition has methodically separated these two populations of menopausal women for analysis. That we now show surgical vs. transitional modes of menopause result in disparate cognitive effects of HT has implications for future research and treatments optimizing HT for menopausal women.

AB - The question of whether to take hormone therapy (HT) will impact every woman as she enters reproductive senescence. In women, studies suggest that ovarian hormone loss associated with menopause has deleterious cognitive effects. Results from clinical studies evaluating whether estrogen-containing HT mitigates these effects, and benefits cognition, are discrepant. Type of menopause, surgical vs. transitional, impacts cognitive outcome in women. However, whether type of menopause impacts cognitive effects of HT has not been methodically tested in women or an animal model. We used the 4-vinylcyclohexene diepoxide rodent model of ovarian follicle depletion, which mimics transitional menopause, and the traditional rat model of menopause, ovariectomy, to cognitively test the most commonly prescribed estrogen therapy in the United States, conjugated equine estrogens (Premarin). Here we show conjugated equine estrogens benefited cognition in surgically menopausal rats, but, in contrast, impaired cognition in transitionally menopausal rats. Androstenedione, released from the residual transitional menopausal ovary, was positively associated with impaired performance, replicating our previous findings in 4-vinylcyclohexene diepoxide animals. The current findings are especially salient given that no clinical study testing cognition has methodically separated these two populations of menopausal women for analysis. That we now show surgical vs. transitional modes of menopause result in disparate cognitive effects of HT has implications for future research and treatments optimizing HT for menopausal women.

UR - http://www.scopus.com/inward/record.url?scp=77954928406&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954928406&partnerID=8YFLogxK

U2 - 10.1210/en.2010-0055

DO - 10.1210/en.2010-0055

M3 - Article

C2 - 20555031

AN - SCOPUS:77954928406

VL - 151

SP - 3795

EP - 3804

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 8

ER -